Jul 24, 2018
Global partners pledge over $1.2 billion to launch the MenStar Coalition
In 2015, the World Health Organization recommended dolutegravir as an alternative first-line treatment for adults and adolescents.
It has become a drug of choice for people living with HIV in high-income countries as it has very few side effects.
Unitaid investments are helping to increase access to affordable dolutegravir in less affluent countries.